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There are three types of osteophytes: the traction spur,
a physiologic response at the insertion of tendons and
ligaments; the inflammatory spur, represented by the
syndesmophyte at the insertion of ligaments and tendons
to bone as seen in ankylosing spondylitis; and the real
osteophyte – or better, osteochondrophyte – arising in the
synovium overlying bone at the junctional zone. The osteo-
chondrophyte is believed to form from metaplasia of syn-
ovium into cartilage with the formation of chondroblasts and
cartilage at the margin of articular surface1–4.
The osteophyte myth is represented by the supposed
diagnostic relevance of tibial spine hypertrophy. In reality,
tibial spines are not ligamentous insertions or traction
spurs, and the peaking of the tibial spines is not a relevant
diagnostic finding1. The osteophytes can be considered to
be an adaptive reaction of the joint to cope with instability.
Osteophytes splint the joint and may play a compensatory
role in the redistribution of forces to provide articular
cartilage protection. It has been shown, at the time of total
knee replacement, that removal of osteophytes from the
arthritic compartment significantly increased the varus-
valgus motion, and subsequent removal of osteophytes
from the nonosteoarthritic compartment further increased
motion. Therefore, these data suggest that osteophytes
appear to stabilize osteoarthritic knees but can cause fixed
deformity5.
The formation of osteophytes is linked to growth factors.
Uchino et al.6 demonstrated that both transforming growth
factor-1 (TGF-1) and basic fibroblast growth factor (bFGF)
are expressed in osteophytes of the femoral head in
osteoarthritis (OA). In a murine model of OA, osteophytes
develop after repeated injections of TGF-1 in the knee and
after sustained overexpression of TGF- in the joint follow-
ing TGF- gene transfer7,8. Interestingly, cartilage lesions
are correlated with the degree of osteophyte formation. A
few studies have shown that bone scintigraphy is a good
marker for growing, active osteophytes and may predict, to
some extent, the future disintegration of the joint9,10.
Clinically, osteophytes of the knee are associated with
pain and predict pain more accurately than the narrowing of
knee joint space in all radiological views11.
The clinical aspects of osteophytes in OA are sum-
marized by K. Brandt12. According to Dr Brandt, antiresorp-
tive drugs inhibit the formation of cancellous subchondral
bone but have no effect on the formation of marginal
osteophytes. Doxycycline has no effect on osteophytes, but
some anti-inflammatory drugs, such as glucocorticoids
that have an anti-anabolic effect, inhibit both cartilage
breakdown and osteophytosis13–15.
However, osteophytes may represent a manifestation
of aging in the absence of other bony changes. In most
cases, they are asymptomatic, but they may be of clinical
importance. For instance, cervical osteophytes may cause
dysphagia, and lumbar osteophytes may be responsible for
nerve root compression with severe pain, requiring surgical
removal16,17.
Does the removal of osteophytes accelerate cartilage
degeneration? Surgeons have shown that after hallux
rigidus cheilectomy there is no cartilage destruction18. Are
osteophytes good or bad? It depends where they are
situated, and it depends on the stage of the disease. At the
endstage of OA in lower limbs they may be good because
they stabilize the joint. However, in the spine, most often,
they are painful, and they are bad.
Discussion
Participant: Magnetic resonance imaging (MRI) can pro-
vide interesting information with regard to the evolution of
osteophytes. As osteophytes evolve, one will typically see
some focal hyperemic or an edema pattern on an MRI
scan. And then, as they mature, they can have a low signal
if they are densely ossified, or even in a late stage, as one
may see bone marrow replacement going into the osteo-
phyte. It might be interesting to determine from both longi-
tudinal and cross-sectional studies the value of MRI in
showing the relationship between osteophytes and the
stage of the disease, the symptoms of disease, and drug
efficacy.
Dr Menkes: The value of MRI is confirmed by the findings
in patients who, for some reason, underwent both bone
scintigraphy and MRI at the same time. An increased
uptake of the radioisotope on the bone scan and a
gadolinium-enhanced imaging on the MRI, corresponding
to a local hyperactivity, appear to be correlated.
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Participant: If we accept that osteophytes are the joint’s
attempt to stabilize joint instability introduced by the
osteoarthritic process, there should be some correlation
between the size or the growth of the osteophyte and other
criteria of joint change, such as loss of joint space or the
size of the focal lesions. Do you know whether anyone has
tried to correlate these or other parameters with the rate of
progression of osteophyte formation?
Dr Dougados: In the ECHODIAH study, we evaluated
radiographic data from 500 patients with hip OA in an effort
to determine the radiographic findings that would predis-
pose patients to disease progression. Progression was
defined by the change in joint space width after 2 years.
The radiological factors found to be predisposing factors for
disease progression were the presence at baseline of
subchondral cysts, osteosclerosis, and osteophytes. We
found that the absence of osteophytes was associated with
a higher risk of progression.
It is possible that the absence of osteophytes is charac-
teristic of a specific group of patients with rapidly destruc-
tive OA of the hip. When collecting information about
osteophytes, it is interesting to take into account other
localizations of the disease.
Dr Buckland-Wright: I wonder if this is not something that
has been described previously, by the South African sur-
geons, who characterized the atrophic and hypertrophic
forms of OA. The atrophic form, which is non-osteophyte
forming, is highly destructive with rapid progression, and
the hypertrophic form is osteophyte forming with a low rate
of progression.
References
1. Alexander CJ. Osteoarthritis: a review of old myths and
current concepts. Skeletal Radiol 1990;19:327–33.
2. Moskowitz R. Bone remodeling in osteo-
arthritis: subchondral and osteophytic responses.
Osteoarthritis Cartilage 1999;7:323–4.
3. Oni OO, Boyd I. The origin of the periarticular osteo-
phytes of osteoarthritic knee joints. Afr J Med Sci
1998;27:23–5.
4. Moskowitz RW, Goldberg VM. Osteophyte evolution:
studies in an experimental partial meniscectomy
model. J Rheumatol 1987;14:166-8.
5. Pottenger LA, Phillips FM, Draganich LF. The effect of
marginal osteophytes on reduction of varus-valgus
instability in osteoarthritic knees. Arthritis Rheum
1990;33:853–8.
6. Uchino M, Izumi T, Tominaga T, Wakita R, Minchara H,
Sekiguchi M, et al. Growth factor expression in
the osteophytes of the human femoral head in
osteoarthritis. Clin Orthop 2000;377:119–25.
7. Van den Berg WB. Osteophyte formation in osteo-
arthritis. Osteoarthritis Cartilage 1999;7:333.
8. Van Beuningen HM, Glansbeek HL, Van der Kraan
PM, Van den Berg WB. Osteoarthritis-like changes
in the murine knee joint resulting from intra-
articular transforming growth factor-beta injections.
Osteoarthritis Cartilage 2000;1:25–33.
9. Van Osch GJ, Van der Kraan PM, Van Valburg AA, Van
den Berg WB. The relation between cartilage dam-
age and osteophyte size in a murine model for
osteoarthritis in the knee. Rheumatol Int 1996;
16:115–9.
10. Dieppe PA, Cushnagan J, Young P, Kirwan J. Bone
scintigraphy predicts the progression of joint space
narrowing in osteoarthritis of the knee. Ann Rheum
Dis 1993;52:557–63.
11. Cicuttini FM, Baker J, Hart DJ, Spector TD. Association
of pain with radiological changes in different compart-
ments and views of the knee joint. Osteoarthritis
Cartilage 1996;4:143–7.
12. Brandt KD. Osteophytes in osteoarthritis. Clinical
aspects. Osteoarthritis Cartilage 1999;7:334–5.
13. Yu LP, Smith GN Jr., Brandt KD, Myers SL, O’Connor
BL, Brandt DA. Reduction of the severity of canine
osteoarthritis by prophylactic treatment with oral
doxycycline. Arthritis Rheum 1992;35:1150–9.
14. Pelletier JP, Martel-Pelletier J. Protective effects of
corticosteroids on cartilage lesions and osteophyte
formation in the Pond-Nuki dog model of
osteoarthritis. Arthritis Rheum 1989;32:181–93.
15. Devogelaer JP, Manicourt DH. Osteophytes and
osteoarthritis progression. Effects of nonsteroidal
antiinflammatory drugs. Osteoarthritis Cartilage
1999;7:336–7.
16. Strasser G, Schima W, Schober E, Pokieser P, Kaider
A, Denk DH. Cervical osteophytes impinging on the
pharynx: importance of size and concurrent disorders
for development of aspiration. Am J Roentgenol
2000;174:449–53.
17. Lamer TJ. Lumbar spine pain originating from vertebral
osteophytes. Reg Anesth Pain Med 1999;24:347–51.
18. Mann RA, Clanton TO. Hallux rigidus: treatment by
cheilectomy. J Bone Joint Surg 1988;30:400–6.
S54 C-J. Menkes and N. E. Lane: Are osteophytes good or bad?
